Glycaemic control is correlated with well-being index (WHO-5) in subjects with type 2 diabetes

Experimental and Clinical Endocrinology and Diabetes

Volumn 118, Issue 6, 2010, Pages 364-367

  Papanas, N ^a   Tsapas, A ^b,c   Papatheodorou, K ^a   Papazoglou, D ^a   Bekiari, E ^b   Sariganni, M ^b   Paletas, K ^b   Maltezos, E ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c Harris Manchester Medical Academy   (United Kingdom)

Author keywords

Diabetes mellitus; Glycaemic control; Neuropathic pain; Quality of life; WHO 5

Indexed keywords

HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; FEMALE; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHIC PAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QUESTIONNAIRE; WELLBEING; WHO 5 WELLBEING INDEX; WORLD HEALTH ORGANIZATION; AGED; ATTITUDE TO HEALTH; BLOOD; COMPLICATION; DIABETIC NEUROPATHIES; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; PSYCHOLOGY;

AGED; ATTITUDE TO HEALTH; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES;

EID: 77953661689     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0029-1243623     Document Type: Article

References (33)

1. Apostolou T, Hutchison AJ, Boulton AJ, et al. Quality of life in CAPD, transplant, and chronic renal failure patients with diabetes. Ren Fail 2007 29 189-197
2. Armstrong DG, Lavery LA, Wrobel JS, et al. Quality of life in healing diabetic wounds: does the end justify the means? J Foot Ankle Surg 2008 47 278-282
3. Awata S, Bech P, Yoshida S, et al. Reliability and validity of the Japanese version of the World Health Organization-Five Well-Being Index in the context of detecting depression in diabetic patients Psychiatry Clin Neurosci 2007 61 112-119
4. Bech P, Olsen LR, Kjoller M, et al. Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being Scale. Int J Methods Psychiatr Res 2003 12 85-91
5. Blackburn H, Keys A, Simonson E, et al. The electrocardiogram in population studies. A classification system. Circulation 1960 21 1160-1175
6. Bloomgarden ZT. Diabetes complications. Diabetes Care 2004 27 1506-1514
7. Bloomgarden ZT. Cardiovascular disease in diabetes. Diabetes Care 2008 31 1260-1266
8. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003 289 2560-2572
9. de Wit M, Pouwer F, Gemke RJ, et al. Validation of the WHO-5 Well-Being Index in adolescents with type 1 diabetes. Diabetes Care 2007 30 2003-2006
10. de Wit M, Delemarre-van de Waal HA, Bokma JA, et al. Self-report and parent-report of physical and psychosocial well-being in Dutch adolescents with type 1 diabetes in relation to glycemic control. Health Qual Life Outcomes 2007b 5 10
11. Eren I, Erdi O, Sahin M. The effect of depression on quality of life of patients with type II diabetes mellitus. Depress Anxiety 2008 25 98-106
12. Fong DS, Aiello L, Gardner TW, et al. Diabetic retinopathy. Diabetes Care 2003 26 (Suppl 1) S99-S102
13. Garber AJ, Wahlen J, Wahl T, et al. Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study). Diabetes Obes Metab 2006 8 58-66
14. Garratt AM, Schmidt L, Fitzpatrick R. Patient-assessed health outcome measures for diabetes: A structured review. Diabet Med 2002 19 1-11 (Pubitemid 34146631)
15. Goykhman S, Drincic A, Desmangles JC, et al. Insulin Glargine: A review 8 years after its introduction. Expert Opin Pharmacother 2009 10 705-718
16. Gumprecht J, Benroubi M, Borzi V, et al. Intensification to biphasic insulin aspart 30/70 (BIAsp 30, NovoMix 30) can improve glycaemic control in patients treated with basal insulins: A subgroup analysis of the IMPROVE observational study. Int J Clin Pract 2009 63 966-972
17. Hajos TRS, Pouwer F, de Grooth R, et al. Improves symptom distress and well-being following initiation of insulin glargine in suboptimally controlled type 2 diabetes patients on oral agents. An observational study. Diabetologia 2009 52 (Suppl 1) A 973
18. Ismail K, Winkley K, Rabe-Hesketh S. Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes. Lancet 2004 363 1589-1597
19. Klein S, Hage JJ. Measurement, calculation, and normal range of the ankle-arm index: A bibliometric analysis and recommendation for standardization. Ann Vasc Surg 2006 20 282-292
20. Logtenberg SJ, van Ballegooie E, Israel-Bultman H, et al. Glycaemic control, health status and treatment satisfaction with continuous intraperitoneal insulin infusion. Neth J Med 2007 65 65-70
21. Molitch ME, DeFronzo RA, Franz MJ, et al. Diabetic nephropathy. Diabetes Care 2003 26 (Suppl 1) S94-S98
22. Papanas N, Papatheodorou K, Papazoglou D, et al. Foot temperature in type 2 diabetic patients with or without peripheral neuropathy. Exp Clin Endocrinol Diabetes 2009 117 44-47
23. Rosen RC, Riley A, Wagner G, et al. The international index of erectile function (IIEF): Multidimensional scale for assessment of erectile dysfunction. Urology 1997 49 822-830
24. Shea S, Skovlund S, Bech P, et al. Routine assessment of psychological well-being in people with diabetes in primary care validation of the WHO-5-Well-being-Index in six countries. Diabetologia 2003 46 A88
25. Tan SM, Shafiee Z, Wu LL, et al. Factors associated with control of type I diabetes in Malaysian adolescents and young adults. Int J Psychiatry Med 2005 35 123-136
26. Tsapas A, Matthews DR. N of 1 trials in diabetes: Making individual therapeutic decisions. Diabetologia 2008 51 921-925
27. Vileikyte L, Peyrot M, Bundy C, et al. The development and validation of a neuropathy- and foot ulcer-specific quality of life instrument. Diabetes Care 2003 26 2549-2555
28. Vileikyte L, Leventhal H, Gonzalez JS, et al. Diabetic peripheral neuropathy and depressive symptoms: The association revisited. Diabetes Care 2005 28 2378-2383
29. Vileikyte L, Peyrot M, Gonzalez JS, et al. Predictors of depressive symptoms in persons with diabetic peripheral neuropathy: a longitudinal study. Diabetologia 2009 52 1265-1273
30. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004 27 1047-1053
31. Winkley K, Ismail K, Landau S, et al. Psychological interventions to improve glycaemic control in patients with type 1 diabetes: ystematic review and meta-analysis of randomised controlled trials. BMJ 2006 333 65
32. Young MJ, Boulton AJ, MacLeod AF, et al. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993 36 150-154
33. Ziegler D. Painful diabetic neuropathy: Treatment and future aspects. Diabetes Metab Res Rev 2008 24 (Suppl 1) S52-S57